Relmada Therapeutics Inc (RLMD)
3.69
+0.05
(+1.37%)
USD |
NASDAQ |
May 01, 16:00
3.72
+0.03
(+0.81%)
After-Hours: 20:00
Relmada Therapeutics Price: 3.69 for May 1, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 01, 2024 | 3.62 | 3.83 | 3.62 | 3.69 | 63998.00 |
| Apr 30, 2024 | 3.53 | 3.74 | 3.46 | 3.64 | 147724.0 |
| Apr 29, 2024 | 3.85 | 3.969 | 3.35 | 3.53 | 241735.0 |
| Apr 26, 2024 | 3.69 | 3.87 | 3.62 | 3.83 | 80013.00 |
| Apr 25, 2024 | 3.79 | 3.81 | 3.66 | 3.70 | 85873.00 |
| Apr 24, 2024 | 3.95 | 3.960 | 3.75 | 3.86 | 114592.0 |
| Apr 23, 2024 | 3.91 | 4.10 | 3.82 | 3.91 | 143632.0 |
| Apr 22, 2024 | 3.99 | 4.060 | 3.70 | 3.87 | 178128.0 |
| Apr 19, 2024 | 4.30 | 4.314 | 3.950 | 4.00 | 152611.0 |
| Apr 18, 2024 | 4.65 | 4.72 | 4.27 | 4.30 | 86256.00 |
| Apr 17, 2024 | 4.62 | 4.72 | 4.52 | 4.68 | 85166.00 |
| Apr 16, 2024 | 4.47 | 4.61 | 4.32 | 4.56 | 63203.00 |
| Apr 15, 2024 | 4.67 | 4.730 | 4.413 | 4.45 | 125022.0 |
| Apr 12, 2024 | 4.61 | 4.68 | 4.54 | 4.65 | 120024.0 |
| Apr 11, 2024 | 4.60 | 4.81 | 4.495 | 4.66 | 117197.0 |
| Apr 10, 2024 | 4.77 | 4.90 | 4.29 | 4.51 | 158446.0 |
| Apr 09, 2024 | 4.92 | 5.09 | 4.745 | 4.80 | 88073.00 |
| Apr 08, 2024 | 4.64 | 4.97 | 4.64 | 4.86 | 63172.00 |
| Apr 05, 2024 | 4.72 | 4.840 | 4.53 | 4.59 | 101194.0 |
| Apr 04, 2024 | 4.75 | 5.03 | 4.66 | 4.69 | 178512.0 |
| Apr 03, 2024 | 4.96 | 5.09 | 4.68 | 4.71 | 144924.0 |
| Apr 02, 2024 | 4.97 | 5.05 | 4.79 | 4.94 | 136600.0 |
| Apr 01, 2024 | 4.65 | 5.00 | 4.60 | 4.88 | 126566.0 |
| Mar 28, 2024 | 4.71 | 4.71 | 4.50 | 4.65 | 113420.0 |
| Mar 27, 2024 | 4.87 | 4.87 | 4.40 | 4.59 | 149749.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.17
Minimum
Dec 08 2022
50.12
Maximum
Feb 26 2020
20.79
Average
22.25
Median
Dec 23 2021
Price Benchmarks
| Cyclacel Pharmaceuticals Inc | 2.680 |
| Lifecore Biomedical Inc | 6.44 |
| Corvus Pharmaceuticals Inc | 1.61 |
| NeuroBo Pharmaceuticals Inc | 3.68 |
| Ensysce Biosciences Inc | 0.6089 |
Price Related Metrics
| PEG Ratio | -1.032 |
| Price to Book Value | 1.304 |
| Earnings Yield | -88.62% |
| Market Cap | 111.34M |
| PEGY Ratio | -1.032 |